Derek Dinart who is a biostatistician working with the BPH-EPICENE team at the Institut Bergonié received the ARC Foundation Prize at the EPICLIN-JSCLCC 2025 conference.

Derek Dinart develops his research projects within the BPH-EPICENE team and the Centre de Lutte Contre le Cancer (CLCC) Bergonié.
He is renowned for his innovative approaches to biostatistics, in particular the use of Bayesian analyses and joint models to optimise the interpretation of complex clinical data.

In 2022, he obtained his doctorate in Public Health, specialising in Biostatistics, from the University of Bordeaux, for a thesis entitled ‘Methods for estimating the sizes of randomised trials in cancerology in the presence of survival data and heterogeneous populations’, carried out under the supervision of Carine Bellera (BPH-EPICENE team, Institut Bergonié) and Virginie Rondeau (BPH-BIOSTAT team).

His expertise covers biostatistical methods applied to oncology, in particular the design and analysis of clinical trials (phases I to III), survival analysis, the integration of biomarkers into trial designs, and the analysis of quality of life data.

Derek recently took part in the EPICLIN-JSCLCC 2025 conference organising committee, where he presented his work entitled ‘Statistical methods for sequential evaluation of treatment lines in cancer using the patient as his own control’.

He was awarded the Association for Cancer Research (ARC) Foundation Prize at this conference, in recognition of his contribution to training in and disseminating cutting-edge statistical methods for use in clinical trials in oncology.